Bio-Techne
TECH
#1476
Rank
$11.95 B
Marketcap
$75.27
Share price
-1.17%
Change (1 day)
-0.99%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Revenue for Bio-Techne (TECH)

Revenue in 2024 (TTM): $1.17 Billion USD

According to Bio-Techne's latest financial reports the company's current revenue (TTM ) is $1.17 Billion USD. In 2023 the company made a revenue of $1.14 Billion USD an increase over the revenue in the year 2022 that were of $1.11 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bio-Techne from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $1.17 B2.32%
2023 $1.14 B2.25%
2022 $1.11 B8.77%
2021 $1.02 B28.86%
2020 $0.79 B7.29%
2019 $0.74 B9.24%
2018 $0.68 B13.74%
2017 $0.59 B13.49%
2016 $0.52 B13.55%
2015 $0.46 B13.86%
2014 $0.40 B23.73%
2013 $0.33 B5.68%
2012 $0.31 B1.91%
2011 $0.30 B12.44%
2010 $0.27 B2.96%
2009 $0.26 B-1.37%
2008 $0.26 B12.46%
2007 $0.23 B12.76%
2006 $0.21 B10.73%
2005 $0.19 B13.71%
2004 $0.16 B9.61%
2003 $0.15 B11.36%
2002 $0.13 B12.99%
2001 $0.12 B12.37%
2000 $0.10 B10.92%
1999 $97.82 M23.67%
1998 $79.1 M24.57%
1997 $63.5 M10.05%
1996 $57.7 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$42.37 B 3,516.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.58 B 120.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.17 B 1,622.29%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.03 B 1,609.65%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.96 B 67.82%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$54.41 B 4,544.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$31.9 M-97.28%๐Ÿ‡บ๐Ÿ‡ธ USA